MARKHAM, Ontario, June 4, 2013 /PRNewswire/ -- Axxess Pharma Inc. (OTC Pink: AXXE), a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products, is pleased to announce the Company is now current in their filings on OTCMarkets.com. The Company is now listed on the OTC Markets website as "Current Information" status. This upgraded listing is expected to increase transparency and investor confidence.
Dr. Daniel Bagi , CEO of Axxess Pharma, Inc. stated, "We are pleased to have accomplished this task for our shareholders. We remain focused on complete transparency and generating revenues by the second half of 2013. As the weeks and months progress, we will continue to release news regarding product licensing, product distribution, revenues, and brand marketing." Dr. Bagi further stated, "During the last 15 months, the company has worked diligently to bolster management, and initiate revenues and profits through our prescription drugs and over-the-counter nutritional supplements."
For more information, please visit www.axxesspharmainc.com, or contact the Company at (416) 410-6006.
About Axxess Pharma, Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, - to optimal health management through improved nutritional supplements.
|SOURCE Axxess Pharma Inc.|
Copyright©2012 PR Newswire.
All rights reserved